Zacks
Is This the Right Time to Hold Thermo Fisher Stock in Your Portfolio?
📊
AI Sentiment
Positive
7/10
- Home
- TMO
as of 03-06-2026 3:38pm EST
$500.92
$17.92
-3.45%
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
| Founded: | 1956 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 191.5B | IPO Year: | 1996 |
| Target Price: | $639.83 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 19 |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | 17.74 | EPS Growth: | 7.32 |
| 52 Week Low/High: | $385.46 - $643.99 | Next Earning Date: | 04-30-2026 |
| Revenue: | $20,918,000,000 | Revenue Growth: | 14.47% |
| Revenue Growth (this year): | 6.17% | Revenue Growth (next year): | 5.21% |
| P/E Ratio: | 29.29 | Index: | |
| Free Cash Flow: | 6.3B | FCF Growth: | -13.40% |
AI-Powered TMO Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 74.38%
74.38%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Thermo Fisher Scientific Inc (TMO)
CASPER MARC N
Sell
Chairman & CEO
TMO Mar 4, 2026
Avg Cost/Share
$513.29
Shares
5,000
Total Value
$2,561,993.83
Owned After
123,925.358
CASPER MARC N
Sell
Chairman & CEO
TMO Mar 3, 2026
Avg Cost/Share
$502.70
Shares
5,000
Total Value
$2,515,494.77
Owned After
123,925.358
Pettiti Gianluca
Sell
Executive Vice President
TMO Feb 9, 2026
Avg Cost/Share
$541.20
Shares
400
Total Value
$216,480.00
Owned After
20,752.223
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| CASPER MARC N | TMO | Chairman & CEO | Mar 4, 2026 | Sell | $513.29 | 5,000 | $2,561,993.83 | 123,925.358 | |
| CASPER MARC N | TMO | Chairman & CEO | Mar 3, 2026 | Sell | $502.70 | 5,000 | $2,515,494.77 | 123,925.358 | |
| Pettiti Gianluca | TMO | Executive Vice President | Feb 9, 2026 | Sell | $541.20 | 400 | $216,480.00 | 20,752.223 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Jan 29, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K SELLJan 29, 2026 · 100% conf.
AI Prediction SELL
1D
-1.02%
$586.10
Act: -2.36%
5D
-2.31%
$578.49
Act: -8.41%
20D
-3.47%
$571.59
Act: -12.22%
Price: $592.16 Prob +5D: 0% AUC: 1.000
0000097745-26-000012
tmo-202601290000097745FALSE00000977452026-01-292026-01-290000097745us-gaap:CommonStockMember2026-01-292026-01-290000097745tmo:A1.45SeniorNotesDue2027Member2026-01-292026-01-290000097745tmo:SeniorNotes175Due2027Member2026-01-292026-01-290000097745tmo:FloatingRateNotesDue2027Member2026-01-292026-01-290000097745tmo:SeniorNotes0.500Due2028Member2026-01-292026-01-290000097745tmo:SeniorNotes1.375Due2028Member2026-01-292026-01-290000097745tmo:SeniorNotes1.95Due2029Member2026-01-292026-01-290000097745tmo:SeniorNotes0.875Due2031Member2026-01-292026-01-290000097745tmo:SeniorNotes2375Due2032Member2026-01-292026-01-290000097745tmo:SeniorNotes3650Due2034Member2026-01-292026-01-290000097745tmo:SeniorNotes3.628Due2035Member2026-01-292026-01-290000097745tmo:SeniorNotes2.875Due2037Member2026-01-292026-01-290000097745tmo:SeniorNotes1.500Due2039Member2026-01-292026-01-290000097745tmo:SeniorNotes1.875Due2049Member2026-01-292026-01-29
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 29, 2026
THERMO FISHER SCIENTIFIC INC.
(Exact name of Registrant as specified in its Charter)
Delaware1-800204-2209186 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
168 Third Avenue Waltham, Massachusetts 02451 (Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (781) 622-1000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $1.00 par valueTMONew York Stock Exchange 1.450% Notes due 2027TMO 27New York Stock Exchange 1.750% Notes due 2027TMO 27BNew York Stock Exchange Floating Rate Notes due 2027TMO 27DNew York Stock Exchange 0.500% Notes due 2028TMO 28ANew York Stock Exchange 1.375% Notes due 2028TMO 28New York Stock Exchange 1.950% Notes due 2029TMO 29New York Stock Exchange 0.875% Notes due 2031TMO 31New York Stock Exchange 2.375% Notes due 2032TMO 32New York Stock Exchange 3.650% Notes due 2034TMO 34New York Stock Exchange 3.628% Notes due 2035TMO 35ANew York Stock Exchange 2.875% Notes due 2037TMO 37New York Stock Exchange 1.500% Notes due 2039TMO 39New York Stock Exchange 1.875% Notes due 2049TMO 49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On January 29, 2026, the Registrant announced its financial results for the fiscal quarter and year ended December 31, 2025. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.
The information contained in this report and exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release dated January 29, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THERMO FISHER SCIENTIFIC INC.
Date:January 29, 2026By:/s/ Joseph R. Holmes Joseph R. Holmes Vice President and Chief Accounting Officer
3
2025 Q3 Q3 2025 Earnings
8-K Oct 22, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 22, 2025
0000097745-25-000150
tmo-202510220000097745FALSE00000977452025-10-222025-10-220000097745us-gaap:CommonStockMember2025-10-222025-10-220000097745tmo:SeniorNotes3200Due2026Member2025-10-222025-10-220000097745tmo:SeniorNotes1.40Due2026Member2025-10-222025-10-220000097745tmo:A1.45SeniorNotesDue2027Member2025-10-222025-10-220000097745tmo:SeniorNotes175Due2027Member2025-10-222025-10-220000097745tmo:SeniorNotes0.500Due2028Member2025-10-222025-10-220000097745tmo:SeniorNotes1.375Due2028Member2025-10-222025-10-220000097745tmo:SeniorNotes1.95Due2029Member2025-10-222025-10-220000097745tmo:SeniorNotes0.875Due2031Member2025-10-222025-10-220000097745tmo:SeniorNotes2375Due2032Member2025-10-222025-10-220000097745tmo:SeniorNotes3650Due2034Member2025-10-222025-10-220000097745tmo:SeniorNotes2.875Due2037Member2025-10-222025-10-220000097745tmo:SeniorNotes1.500Due2039Member2025-10-222025-10-220000097745tmo:SeniorNotes1.875Due2049Member2025-10-222025-10-22
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 22, 2025
THERMO FISHER SCIENTIFIC INC.
(Exact name of Registrant as specified in its Charter)
Delaware1-800204-2209186 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
168 Third Avenue Waltham, Massachusetts 02451 (Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (781) 622-1000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $1.00 par valueTMONew York Stock Exchange 3.200% Notes due 2026TMO 26BNew York Stock Exchange 1.400% Notes due 2026TMO 26ANew York Stock Exchange 1.450% Notes due 2027TMO 27New York Stock Exchange 1.750% Notes due 2027TMO 27BNew York Stock Exchange 0.500% Notes due 2028TMO 28ANew York Stock Exchange 1.375% Notes due 2028TMO 28New York Stock Exchange 1.950% Notes due 2029TMO 29New York Stock Exchange 0.875% Notes due 2031TMO 31New York Stock Exchange 2.375% Notes due 2032TMO 32New York Stock Exchange 3.650% Notes due 2034TMO 34New York Stock Exchange 2.875% Notes due 2037TMO 37New York Stock Exchange 1.500% Notes due 2039TMO 39New York Stock Exchange 1.875% Notes due 2049TMO 49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 22, 2025, the Registrant announced its financial results for the fiscal quarter ended September 27, 2025. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.
The information contained in this report and exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release dated October 22, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THERMO FISHER SCIENTIFIC INC.
Date:October 22, 2025By:/s/ Joseph R. Holmes Joseph R. Holmes Vice President and Chief Accounting Officer
3
2025 Q2 Q2 2025 Earnings
8-K Jul 23, 2025
2025
Q2
Q2 2025 Earnings
8-KJul 23, 2025
0000097745-25-000093
tmo-202507230000097745FALSE00000977452025-07-232025-07-230000097745us-gaap:CommonStockMember2025-07-232025-07-230000097745tmo:SeniorNotes3200Due2026Member2025-07-232025-07-230000097745tmo:SeniorNotes1.40Due2026Member2025-07-232025-07-230000097745tmo:A1.45SeniorNotesDue2027Member2025-07-232025-07-230000097745tmo:SeniorNotes175Due2027Member2025-07-232025-07-230000097745tmo:SeniorNotes0.500Due2028Member2025-07-232025-07-230000097745tmo:SeniorNotes1.375Due2028Member2025-07-232025-07-230000097745tmo:SeniorNotes1.95Due2029Member2025-07-232025-07-230000097745tmo:SeniorNotes0.875Due2031Member2025-07-232025-07-230000097745tmo:SeniorNotes2375Due2032Member2025-07-232025-07-230000097745tmo:SeniorNotes3650Due2034Member2025-07-232025-07-230000097745tmo:SeniorNotes2.875Due2037Member2025-07-232025-07-230000097745tmo:SeniorNotes1.500Due2039Member2025-07-232025-07-230000097745tmo:SeniorNotes1.875Due2049Member2025-07-232025-07-23
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 23, 2025
THERMO FISHER SCIENTIFIC INC.
(Exact name of Registrant as specified in its Charter)
Delaware1-800204-2209186 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
168 Third Avenue Waltham, Massachusetts 02451 (Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (781) 622-1000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $1.00 par valueTMONew York Stock Exchange 3.200% Notes due 2026TMO 26BNew York Stock Exchange 1.400% Notes due 2026TMO 26ANew York Stock Exchange 1.450% Notes due 2027TMO 27New York Stock Exchange 1.750% Notes due 2027TMO 27BNew York Stock Exchange 0.500% Notes due 2028TMO 28ANew York Stock Exchange 1.375% Notes due 2028TMO 28New York Stock Exchange 1.950% Notes due 2029TMO 29New York Stock Exchange 0.875% Notes due 2031TMO 31New York Stock Exchange 2.375% Notes due 2032TMO 32New York Stock Exchange 3.650% Notes due 2034TMO 34New York Stock Exchange 2.875% Notes due 2037TMO 37New York Stock Exchange 1.500% Notes due 2039TMO 39New York Stock Exchange 1.875% Notes due 2049TMO 49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On July 23, 2025, the Registrant announced its financial results for the fiscal quarter ended June 28, 2025. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.
The information contained in this report and exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release dated July 23, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THERMO FISHER SCIENTIFIC INC.
Date:July 23, 2025By:/s/ Joseph R. Holmes Joseph R. Holmes Vice President and Chief Accounting Officer
3
Latest Thermo Fisher Scientific Inc News
TMO Breaking Stock News: Dive into TMO Ticker-Specific Updates for Smart Investing
Simply Wall St.
Thermo Fisher Expands Drug Discovery And Diagnostics While Shares Lag Targets
📊
AI Sentiment
Positive
7/10
MT Newswires
Thermo Fisher Scientific Insider Sold Shares Worth $5,077,489, According to a Recent SEC Filing
➖
AI Sentiment
Neutral
4/10
GlobeNewswire
Food Inspection Devices Company Evaluation Report 2025: AI-Powered Contaminant Detection and Advanced X-Ray Inspection Systems Strengthen Leadership of Mettler-Toledo, Thermo Fisher Scientific, Ishida
📈
AI Sentiment
Highly Positive
8/10
Business Wire
Thermo Fisher Scientific Opens Bay Area Cryo-EM Drug Discovery Center to Accelerate Breakthrough Therapies
📈
AI Sentiment
Highly Positive
10/10
![[Latest] Global Malaria Diagnostics Market Size/Share Worth USD 1.45 Billion by 2035 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](/cdn/transform/width=500,quality=90,format=webp/https://cdn.finquota.com/news/fc4ac9e7-8ad1-4c51-9917-253265efdf75.png)
![[Latest] Global Microplate Systems Market Size/Share Worth USD 2.88 Billion by 2035 at a 10.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](/cdn/transform/width=500,quality=90,format=webp/https://cdn.finquota.com/news/def1607e-3042-47a1-b6a8-cc56940c103d.png)
Compare TMO vs Leading Stocks
See how TMO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TMO Thermo Fisher Scientific Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.